0001415889-23-004083.txt : 20230303
0001415889-23-004083.hdr.sgml : 20230303
20230303161229
ACCESSION NUMBER: 0001415889-23-004083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Napolitano Richard J
CENTRAL INDEX KEY: 0001599417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 23704063
MAIL ADDRESS:
STREET 1: MSCI INC., 7 WORLD TRADE CENTER
STREET 2: 250 GREENWICH STREET, 49TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
form4-03032023_090302.xml
X0306
4
2023-03-01
0001477449
Teladoc Health, Inc.
TDOC
0001599417
Napolitano Richard J
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
false
true
false
false
CHIEF ACCOUNTING OFFICER
Common Stock
2023-03-01
4
M
0
1347
A
4155
D
Common Stock
2023-03-01
4
M
0
2259
A
6414
D
Common Stock
2023-03-02
4
S
0
1384
25.362
D
5030
D
Restricted Stock Units
2023-03-01
4
M
0
1347
0
D
Common Stock
1347
2696
D
Restricted Stock Units
2023-03-01
4
M
0
2259
0
D
Common Stock
2259
4519
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2023-03-03